Medtech access doubts in ambulance call gaps
This article was originally published in Clinica
UK ambulance trusts have been accused of varying the way they measure emergency response times, potentially in breach of targets established to meet cardiac arrest survival limits. Such a practice could conceal poor performance or, indeed, the impossibility of meeting the target - either way, the situation raises the question of how best to guarantee speed of access to life-saving technology.
You may also be interested in...
Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.
Krka’s bottom line continues to be stronger than usual, driven by a hike in sales and leaner cost base. Looking to 2021, however, management brought investors back down to earth.
The COVID-19 pandemic has triggered extraordinary levels of collaboration. But competition remains, and many newly created coalitions have yet to be stress tested.